Skip to main navigation Skip to search Skip to main content

The Early-Onset Alzheimer's Disease Whole-Genome Sequencing Project: Study design and methodology

  • Nicholas R. Ray
  • , Temitope Ayodele
  • , Melissa Jean-Francois
  • , Penelope Baez
  • , Victoria Fernandez
  • , Joseph Bradley
  • , Paul K. Crane
  • , Clifton L. Dalgard
  • , Amanda Kuzma
  • , Heather Nicaretta
  • , Rebecca Sims
  • , Julie Williams
  • , Michael L. Cuccaro
  • , Margaret A. Pericak-Vance
  • , Richard Mayeux
  • , Li San Wang
  • , Gerard D. Schellenberg
  • , Carlos Cruchaga
  • , Gary W. Beecham*
  • , Christiane Reitz*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

INTRODUCTION: Sequencing efforts to identify genetic variants and pathways underlying Alzheimer's disease (AD) have largely focused on late-onset AD although early-onset AD (EOAD), accounting for ∼10% of cases, is largely unexplained by known mutations, resulting in a lack of understanding of its molecular etiology. METHODS: Whole-genome sequencing and harmonization of clinical, neuropathological, and biomarker data of over 5000 EOAD cases of diverse ancestries. RESULTS: A publicly available genomics resource for EOAD with extensive harmonized phenotypes. Primary analysis will (1) identify novel EOAD risk loci and druggable targets; (2) assess local-ancestry effects; (3) create EOAD prediction models; and (4) assess genetic overlap with cardiovascular and other traits. DISCUSSION: This novel resource complements over 50,000 control and late-onset AD samples generated through the Alzheimer's Disease Sequencing Project (ADSP). The harmonized EOAD/ADSP joint call will be available through upcoming ADSP data releases and will allow for additional analyses across the full onset range. Highlights: Sequencing efforts to identify genetic variants and pathways underlying Alzheimer's disease (AD) have largely focused on late-onset AD although early-onset AD (EOAD), accounting for ∼10% of cases, is largely unexplained by known mutations. This results in a significant lack of understanding of the molecular etiology of this devastating form of the disease. The Early-Onset Alzheimer's Disease Whole-genome Sequencing Project is a collaborative initiative to generate a large-scale genomics resource for early-onset Alzheimer's disease with extensive harmonized phenotype data. Primary analyses are designed to (1) identify novel EOAD risk and protective loci and druggable targets; (2) assess local-ancestry effects; (3) create EOAD prediction models; and (4) assess genetic overlap with cardiovascular and other traits. The harmonized genomic and phenotypic data from this initiative will be available through NIAGADS.

Original languageEnglish
Pages (from-to)4187-4195
Number of pages9
JournalAlzheimer's and Dementia
Volume19
Issue number9
DOIs
StatePublished - Sep 2023
Externally publishedYes

Keywords

  • Alzheimer's disease
  • early-onset Alzheimer's disease
  • genetics
  • study design
  • whole-genome sequencing

Fingerprint

Dive into the research topics of 'The Early-Onset Alzheimer's Disease Whole-Genome Sequencing Project: Study design and methodology'. Together they form a unique fingerprint.

Cite this